Literature DB >> 1955715

Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine.

R S Daum1, G R Siber, G A Ballanco, S K Sood.   

Abstract

Eight healthy adults and 48 infants 2 and 4 months old were immunized with Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine (PRP-OMP) to evaluate antibody kinetics in the first days after immunization. Five adults (63%) had some decrease in antibody, although the geometric mean did not decrease significantly. With one exception, the nadir occurred on postimmunization day 3. Seven had an antibody increase by day 7. Of the children, 6 (75%) of 8 and 17 (77%) of 23 had a decrease in antibody in serum obtained on day 2-3 after the first or second dose, respectively, the magnitude of which directly correlated with the preimmunization antibody concentration. However, the geometric mean did not decrease significantly. Within 1 week of immunization, 85% of infants had an increase in antibody, significantly greater after the second dose than after the first. A high concentration of maternally derived antibody before immunization correlated negatively with antibody response. Thus, a transient decrease in antibody occurs in most adults and infants 2-3 days after immunization with PRP-OMP followed by a prompt increase by day 7.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955715     DOI: 10.1093/infdis/164.6.1154

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.

Authors:  Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

Review 2.  Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability.

Authors:  Carl T D'Angio
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

3.  The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants.

Authors:  G H Chung; K H Kim; R S Daum; R A Insel; G R Siber; S Sood; R K Gupta; C Marchant; M H Nahm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 4.  Maternal vaccination: moving the science forward.

Authors:  Azure N Faucette; Benjamin L Unger; Bernard Gonik; Kang Chen
Journal:  Hum Reprod Update       Date:  2014-07-11       Impact factor: 15.610

5.  Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.

Authors:  Rebecca L Tallmadge; Steven C Miller; Stephen A Parry; Maria Julia B Felippe
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

6.  Haemophilus influenzae Type b Meningitis in the Short Period after Vaccination: A Reminder of the Phenomenon of Apparent Vaccine Failure.

Authors:  Noa Greenberg-Kushnir; Orly Haskin; Havatzelet Yarden-Bilavsky; Jacob Amir; Efraim Bilavsky
Journal:  Case Rep Infect Dis       Date:  2012-08-16

Review 7.  The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.

Authors:  Abigail Morales-Sánchez; Ezequiel M Fuentes-Panana
Journal:  Cancers (Basel)       Date:  2018-03-30       Impact factor: 6.639

Review 8.  Targeting regulatory T cells to improve vaccine immunogenicity in early life.

Authors:  Jorjoh Ndure; Katie L Flanagan
Journal:  Front Microbiol       Date:  2014-09-11       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.